Applied UV Subsidiary Sterilumen Has Been Granted Canadian Patent Number 3127069 Titled “System For Neutralizing Pathogens On Tactile Surfaces” – Canadian Patent Database

MPC's robust Q4 FY23 performance reveals resilience, with revenue and other income reaching $36.82 billion, exceeding the $35.25 billion consensus. While income from operations dipped to $3.73 billion, adjusted EPS surged to $3.98, outpacing the expected $2.20. The company's strong financial position is evident with $10.2 billion in available funds.